| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819934 | Respiratory Medicine | 2018 | 35 Pages |
Abstract
We observed a high burden adult pneumococcal CAP in Europe despite use of the 23-valent pneumococcal polysaccharide vaccine, particularly in elderly patients with comorbidities. CAP surveillance presented wide variations across Europe. Pneumococcal CAP has to be monitored very carefully due to the possible effect of current vaccination strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Antoni Torres, Catia Cillóniz, Francesco Blasi, James D. Chalmers, Jacques Gaillat, Nathalie Dartois, Heinz-Josef Schmitt, Tobias Welte,